BioWorld

Aug. 9, 2002

PTO Fee Proposal Would Have Significant Impact On Biotech

WASHINGTON - If the U.S. Patent and Trademark Office wins approval of its proposed fee structure increase, biotechnology companies filing applications for patents could see their costs skyrocket. (BioWorld Today) Read More

Serono To Market Genentech's Raptiva In Europe, Other Areas

Academia, Military Contrive Triple-Cocktail Antibody Drug To Quash Botulinum Toxin Terrorism Threat

Anadys Lands Its Largest Deal, Signs Collaboration With Roche

Other News To Note

Appointments And Advancements

Wanted: Drug Delivery Firms And Information About Them

Today's news in brief

BioWorld

BioWorld briefs for Dec. 17, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 17, 2024.

Second insulin receptor offers new therapeutic avenues

BioWorld Science

Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Drug duo to Repare lack in gyno cancers? Phase I shows promise

BioWorld

Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...